| SCHEDULE OF LOSS PER SHARE |
For
the three and nine months ended September 30, 2026 and 2025, loss per share of the Company is as follows:
SCHEDULE OF LOSS PER SHARE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three
Months Ended September
30 | | |
Nine
Months Ended September
30 | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Numerator: | |
| | |
| | |
| | |
| |
| Net
Loss | |
$ | (1,869,895 | ) | |
$ | (399,897 | ) | |
$ | (2,608,351 | ) | |
$ | (1,241,708 | ) |
| Net
loss attributable to common stockholders | |
$ | (1,869,895 | ) | |
$ | (399,897 | ) | |
$ | (2,608,351 | ) | |
$ | (1,241,708 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted
average common shares outstanding, basic and diluted | |
| 16,072,267 | | |
| 16,072,267 | | |
| 16,072,267 | | |
| 14,950,840 | |
| Net
loss per share attributable to common stockholders, basic and diluted | |
$ | (0.12 | ) | |
$ | (0.02 | ) | |
$ | (0.16 | ) | |
$ | (0.08 | ) |
|
| SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE |
The
Company excluded the following from the computation of diluted net loss per share attributable to common shareholders for the three months
ended September 30, 2026 and 2025 because including them would have had an anti-dilutive effect:
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three
Months Ended September
30 | | |
Nine
Months Ended September
30 | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Shares
issuable upon exercise of stock options | |
| 1,759,211 | | |
| 1,759,211 | | |
| 1,759,211 | | |
| 1,759,211 | |
| Warrants
to purchase common stock outstanding | |
| 350,000 | | |
| 350,000 | | |
| 350,000 | | |
| 350,000 | |
| Total | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | |
| Anti-dilutive shares | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | | |
| 2,109,211 | |
|